AU2001250821A1 - Methods and compositions for the treatment and prevention of erectile dysfunction - Google Patents

Methods and compositions for the treatment and prevention of erectile dysfunction

Info

Publication number
AU2001250821A1
AU2001250821A1 AU2001250821A AU5082101A AU2001250821A1 AU 2001250821 A1 AU2001250821 A1 AU 2001250821A1 AU 2001250821 A AU2001250821 A AU 2001250821A AU 5082101 A AU5082101 A AU 5082101A AU 2001250821 A1 AU2001250821 A1 AU 2001250821A1
Authority
AU
Australia
Prior art keywords
prevention
compositions
treatment
methods
erectile dysfunction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001250821A
Inventor
Martha Jo Whitehouse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of AU2001250821A1 publication Critical patent/AU2001250821A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
AU2001250821A 2000-03-10 2001-03-09 Methods and compositions for the treatment and prevention of erectile dysfunction Abandoned AU2001250821A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18848000P 2000-03-10 2000-03-10
US60188480 2000-03-10
US20341500P 2000-05-11 2000-05-11
US60203415 2000-05-11
PCT/US2001/007702 WO2001068125A2 (en) 2000-03-10 2001-03-09 Methods and compositions for the treatment and prevention of erectile dysfunction

Publications (1)

Publication Number Publication Date
AU2001250821A1 true AU2001250821A1 (en) 2001-09-24

Family

ID=26884116

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001250821A Abandoned AU2001250821A1 (en) 2000-03-10 2001-03-09 Methods and compositions for the treatment and prevention of erectile dysfunction

Country Status (3)

Country Link
US (1) US20020032153A1 (en)
AU (1) AU2001250821A1 (en)
WO (1) WO2001068125A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001024809A1 (en) * 1999-10-01 2001-04-12 Duke University A method of treating erectile dysfunction
US6852323B2 (en) * 2000-07-21 2005-02-08 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
US9925087B2 (en) 2000-09-15 2018-03-27 Bruder Healthcare Company, Llc Wound and therapy compress and dressing
US10105259B2 (en) 2000-09-15 2018-10-23 Bruder Healthcare Company, Llc Wound and therapy compress and dressing
EP1328225B1 (en) 2000-09-15 2010-03-10 Bruder Healthcare Company Wound and therapy compress and dressing
US20040072294A1 (en) * 2002-06-19 2004-04-15 Braunhut Susan J. Tissue reconstruction and regeneration
KR20130021315A (en) * 2011-08-22 2013-03-05 인하대학교 산학협력단 Composition for preventing or treating erectile dysfunction comprising dkk2 protein or gene therefor and use thereof
US9107737B2 (en) * 2011-11-21 2015-08-18 Alan Schwartz Goggles with facial conforming eyepieces
WO2014143139A1 (en) 2013-03-15 2014-09-18 Bruder Healthcare Company Wound and therapy compress and dressing
AU2016205336A1 (en) 2015-01-06 2017-08-03 Venturis Therapeutics, Inc. Angiogenic treatment of ischemic heart disease
EP3259012A4 (en) * 2015-02-16 2018-09-19 CardioVascular BioTherapeutics, Inc. Therapeutic angiogenesis for treating erectile conditions
US20210267793A1 (en) * 2016-03-01 2021-09-02 Bruder Healthcare Company, Llc Self-heating compress for moist heat delivery
US20190216639A1 (en) * 2016-03-01 2019-07-18 Bruder Healthcare Company, Llc Therapeutic eye compress system
US20200337893A1 (en) * 2016-03-01 2020-10-29 Bruder Healthcare Company, Llc Therapeutic thermal compress with phase-change material
USD844795S1 (en) 2016-11-30 2019-04-02 Bruder Healthcare Company, Llc Therapeutic eye mask
USD871598S1 (en) 2016-11-30 2019-12-31 Bruder Healthcare Company, Llc Therapeutic eye mask
US20220395558A1 (en) * 2019-07-12 2022-12-15 Vasanthi PALANIVEL Compositions for treatment of erectile dysfunction, methods for preparing the same and applications thereof
WO2021009662A1 (en) * 2019-07-12 2021-01-21 Vasanthi Palanivel Compositions for treatment of infertility caused by poor semen quality, methods for preparing the same and applications thereof
US20220249612A1 (en) * 2019-07-15 2022-08-11 Vasanthi PALANIVEL Compositions for treatment of azoospermia, methods for preparing the same and applications thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155214A (en) * 1984-03-05 1992-10-13 The Salk Institute For Biological Studies Basic fibroblast growth factor
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
WO2000013701A2 (en) * 1998-09-03 2000-03-16 Chiron Corporation Angiogenically effective unit dose of fgf-2 and method of use
US6706682B2 (en) * 1999-01-21 2004-03-16 The Trustees Of Columbia University In The City Of New York Uses of vascular endothelial growth factor in the treatment of erectile dysfunction
WO2001024809A1 (en) * 1999-10-01 2001-04-12 Duke University A method of treating erectile dysfunction
EP1232264B1 (en) * 1999-11-18 2009-10-21 Novartis Vaccines and Diagnostics, Inc. Human fgf-21 gene and gene expression products

Also Published As

Publication number Publication date
WO2001068125A3 (en) 2002-03-21
WO2001068125A2 (en) 2001-09-20
US20020032153A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2001250821A1 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
AU6147401A (en) Compositions and methods for the treatment of cancer
AUPR105400A0 (en) Processes and compositions for water treatment
WO2001078781A8 (en) Methods for prevention and treatment of gastrointestinal disorders
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2001239052A1 (en) Compositions for prevention and treatment of dementia
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
AU2002237667A1 (en) Methods for the treatment and prevention of urinary stone disease
HUP0302718A3 (en) Methods and compositions for the treatment of diseases of the eye
IL162154A0 (en) Prostagandin composition for the treatment of erectile dysfunction
EP1161255A4 (en) Methods and compositions for treating erectile dysfunction
PL368035A1 (en) Compositions and methods for the treatment of cancer
HUP0303178A3 (en) Methods and compositions for reducing the taste of pharmaceutically active agents
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU8906201A (en) Methods and compositions for the treatment and prevention of sexual dysfunction
AU2002246924A1 (en) Treatment of erectile dysfunction with rho-kinase inhibitors
AU7652400A (en) Novel combination for the treatment of sexual dysfunction
AU2002303552A8 (en) Methods and compositions for prevention of angioproliferation
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2001281396A1 (en) Novel compositions and methods for treatment of male erectile dysfunction
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases
AU2000265105A1 (en) Methods and compositions for the prevention and treatment of syndrome x
AU2335601A (en) Treatment or prevention of diarrhea
PL358267A1 (en) Composition for the prevention and/or treatment of the cytotoxic effects induced by the use of immunosuppressive agents